Tang Kevin C's Form 4 filing
TCR2 Therapeutics Inc. (TCRR) · filed May 15, 2023
- Accession no.
- 0001209191-23-029527
- Filed
- May 15, 2023, 5:12 PM ET
- Trade date
- May 11-12, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $87.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tang Kevin CCIK 0001178579 | 10% Owner |
| Tang Capital Partners LPCIK 0001191935 | 10% Owner |
| Tang Capital Management LLCCIK 0001232621 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 11, 2023 | Common Stock | PPurchaseAcquired | +38,765 | $1.95 | +$75,591.75 | 4,338,617 | Indirect | |
| May 12, 2023 | Common Stock | PPurchaseAcquired | +6,183 | $1.95 | +$12,056.85 | 4,344,800 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.